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1. Introduction 
In various biological systems, the bulk of biogenic 
amines is stored in specialised cell organelles. Among 
the best known examples we find chromaffin vesicles 
from the adrenal medulla [1,2], 5-hydroxy tryptamine 
(5-HT) containing ranules in blood platelets [3], 
histamine granules in mast cells [4] and neuronal 
synaptic vesicles [S]. These vesicles play a central role 
in storage and release of hormones and neurotrans- 
mitters [6]. In addition they are able to actively accu- 
mulate biogenic amines (71. Synaptic vesicles have 
therefore been implicated in termination of synaptic 
transmission. The sequence proposed [6] is removal 
of the neurotransmitters f om the synaptic left by a 
high-affinity uptake system, located in the plasma 
membrane, and their subsequent accumulation i  the 
synaptic vesicles. These two uptake systems differ in 
their drug sensitivity and ion dependence. While the 
transport hrough the plasma membrane isdriven by 
a Na’ gradient [71, the driving force for accumulation 
in the synaptic vesicles remains to be clarilied. 
In chromaff~ vesicles from adrenal medulla 18-l 0] 
and S-HT-containing granules from platelets (Rudnick 
and S.S., in preparation) it has been shown that the 
transmembrane pHgradient has a role in biogenic 
amine uptake, In chromaffin granules it has been 
proposed that a membr~e-bound proton-tr~slocat~g 
Mg”-ATPase generates the pH gradient [I 1 ,121;. 
In the light of these observations, we have investi- 
gated the role of a pH gradient on S-HT uptake by 
synaptic vesicles. 
2. Materials and methods 
A crude synaptosomal fraction was prepared from 
rat brain essentially as in [ 13,141. The mitochondrial 
pellet before the Ficoll gradient was washed once 
more, collected by centrifugation and resuspended in 
90 ml final vol. of a solution containing 5mM Tris-HCl 
buffer (pH 7.4) and 1 mM potassium EDTA and 
stirred for 45 min at 0-4°C. After centrifugation of 
the lysate for 20 min at 20 000 X g the pellet was 
discarded. The crude synaptic vesicle preparation was 
obtained by centrifugating the supernatant for 60 mm 
at 100 000 X g. The pellet obtained was resuspended 
in a 0.3 M sucrose solution containing 10 mM K-Hepes 
(pH 7.4) at 5-7 mg protein/ml and stored in liquid 
air. This preparation was stable for at least 4 weeks. 
ATPdependent ransport was assayed at 30°C in 
0.2 ml medium containing (final cont.) 0.3 M sucrose, 
1OmM potassiumHepes(pH8.5),  mMKCl,2.5 mM 
MgS04, 5 mM ATP and 0.09 m 5- [ 1, 2-3H (N)]hydroxy 
tryptamine creatinine sulfate (27.8 Ci/mmol). The 
reaction was initiated by addition of a small aliquot 
(10 ~1) of membranes vesicles containing 50-70 pg 
protein. At the indicated times,uptake was terminated 
and assayed as in [lo]. 
Thin-layer chromatography of the accumulated 
radioactivity was performed with the material collected 
from 5-HT uptake at 5 min. The filters were extracted 
overnight in 2 ml 0.02 M acetic acid at 4’C in the 
dark. The solvent system used was 15% (v/v) acetic 
acid, 60% (v/v) in butanol, 25% (v/v) H1O. Protein was 
determined as in [ 15’1. 
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5-[ 1, 2-3H (N)Jhydroxytryptamine creatinine sul- 
fate (27.8 Cilmmol) was purchased from NEN. Nige- 
ricin was a generous gift of Dr R. J. Hosley of the 
Eli Lilly Co. All other chemicals were reagent grade 
obtained from commercial sources. 
3. Results and discussion 
3.1.5HT uptake is ATP-dependent and reserpine- 
sensitive 
Upon addition of ATP to a suspension of synaptic 
vesicles, a rapid uptake of S-HT is observed (fig. 1 A). 
This uptake is linear for -1 min and slowly levels off. 
The m~imum amount of 5-HT accumulated after 
5 min is 125 pmol/mg protein-‘. Thereafter the 5-HT 
content of the synaptic vesicles slowly decreases, In 
the absence of externally added ATP, the level of 
5-HT accumulation is only 25% of the uptake in the 
presence of ATP. Reserpine, a potent inhibitor of 
ATP-dependent catecholamine transport in chromaffn 
granules [ 161 also strongly inhibits the a~~umuiation 
of 5-HT in the crude synaptic vesicle preparation 
(fig.lA). 
Imipramine, a well-known inhibitor of Na’-depen- 
dent biogenic amine accumulation has no effect on the 
uptake into synaptic vesicles (table 1). This differential 
sensitivity as well as the ATP requirement and the 
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Fig.1 A. Effectsof ATP, ionophore and inhibitor on 5-[ 3H]HT 
transport in synaptic vesicles. Transport assayswere performed 
as in section 2 except that ATP was omitted from one of the 
reaction media (4-b). No additions (o-o); nigericin, 
2.5 JIM (o-0); reserpine, 1.25 JIM (A-A). 
Fig.lB. Efflux of S-[‘HINT from synaptic vesicles. Transport 
assayswere performed as in fig.1 A. After 3 min of uptake, the 
following additions were made: none (o--o); 5-NT, 50 PM 
(o-c); nigericin, 5 )LM (*---0). 
Table 1 
Differential effects of sodium and imipramine on S-HT 
uptake in synaptic vesicles and synaptosomes 
--._ 
Medium 
composition 
Synaptosomal Synaptic 
fraction vesicles 
(% control) 
No sodium 
Sodium 
Sodium + 
imipramine 
9 74 
100 100 
29 123 
The incubation medium contained 127.2 mM NaCI, 5 mM 
KCI, 2.7 mM CaCI,, 1.3 mM MgSO,, 2.5 mM Tris (pH 7.4) 
0.09 FM S-[ 3H]HT. In addition 11 .I mM D-glucose was 
present in the synapto~mal assay medium and 5 mM ATP 
was added in the case of synaptic vesicles. For uptake in the 
absence of sodium, NaCl was replaced by an equimolar 
amount of KCI. Imipramine, when present, was added to 
2 PM final cont. Assays of the synaptosomes were performed 
within 45 min of fractionation [ 23). Control uptake values 
were 14 pmol/mg protein/min for synaptosomes and 5.7 
pmol/mg protein/min for synaptic vesicles 
Na’ independence of the latter process (table 1) sup- 
port the contention that the uptake observed is due 
to the activity of synaptic vesicles. 
When an excess of unlabelled S-NT is added, after 
3 min of uptake, a rapid efflux of the pre-accumulated 
radioactivity is observed (fig.1 B). This radioactivity 
represents unmodified 5-HT since > 70% of the radio- 
activity co-migrates with authentic 5-HT on thin-layer 
chromatography. 
Assuming an internal volume of -3 pl/mg protein 
[ 171 and maximal uptake of 140 pmol 5-HT/mg pro- 
tein, the vesicles concentrate 5-HT at least 500-fold. 
This value is most probably an underestimate since it 
is likely that only a fraction of the vesicle population 
is active in 5-HT uptake. 
3.2. Effect of ionophores on 5-HT uptake 
In chromaffin granules it appears that it is the 
ApH component of the protonmotive force generated 
by the membrane ATPase, which is the immediate 
driving force for the accumulation of biogenic amines 
[8-l 0,181. In order to determine whether the same 
kind of mech~ism operates in synaptic vesicles from 
rat brain, we have examined the effect of ionophores 
on the transport process. 
Nigericin, known to collapse ApH by exchanging 
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K’/H’, strongly inhibits 5-HT uptake (fig.lA). More- 
over, when added after 3 min of uptake it induces a 
rapid efflux of pre-accumulated S-HT (fig. 1 B). On the 
other hand, v~inomyc~, collapsing Aik under our 
conditions, does not significantly inhibit 5HT uptake 
(data not shown). Qualitatively similar results are also 
obtained with either radioactive epinephrine or nor- 
epinephrine (data not shown). Therefore, it is suggested 
that also in synaptic vesicles, biogenic amine transport 
is driven by a pH gradient and that A* does not 
significantly contribute to the uptake. This conclu- 
sion is supported by a study on norepinephrine uptake 
in synaptic vesicles [ 191. 
3.3. Kinetic constants and ~~~ro~~e of 5HT uptake 
The pH profile of the ATP-dependent uptake in 
synaptic vesicles (fig.2) is remarkably similar to the 
analogous process in chromaffin granules [20]. Thus, 
in both systems the pH optimum as ?H 8.3. As with 
chromaftin granules, this preparation is capable of 
accumulating amines such as norepinephrine ([ 191, 
R.M. unpublished observations), dopamine 1211, 
epinephrine (R.M. unpublished observations) and 
S-HT. In the former preparation it was suggested that 
the uptake of the different amines is mediated by a 
single carrier protein. Since the synaptic vesicles are 
not homogeneous and their amine content is unknown, 
I 1 
0 9 
PH [61 
Fig.2. pH profile of S-[aH]HT transport in synaptic vesicles. 
Assays were performed as in fig.1 A for 3 min except that the 
medium pH was as indicated and the buffers used (10 mM) 
were, K-Hepes (o-o); K-Tris hydroxymethyl methyl- 
aminopropane sulfonate (0-a); K-cyclohexylamino- 
propane sulfonate (A--a). 
17 
[8 I 
a kinetic approach does not lead to unequivocal con- 
clusions. S-HT uptake is a saturable process. The app. 
Km is 1 .O @VI and the I’,, 2 12.0 pmolfmg 
protein/m~. Norep~eph~e is a competitive inhib- 
itor of this uptake with app. Ki 1.2 PM. This Ki is 
similar to the app. Km reported for norepinephrine 
uptake [ 191. 
The results presented here and in [ 191 support 
the contention that biogenic amine uptake in synaptic 
vesicles is driven by a tr~smembr~e pH gradient. 
Direct support for the above notion may be achieved 
by imposition of artificial pH gradients. However, 
such experiments are not feasible when only a small 
percentage of the population contains a reserpine- 
sensitive carrier, since amines may equilibrate with a 
pH gradient even in the absence of a carrier 1221. Thus 
the direct demonstration of the role of a pH gradient 
in S-I-IT uptake will have to await the further purifica- 
tion of the vesicles. 
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